Rainbow Childrens Medicare Limited shareholders approved a ₹3.5 per equity share dividend for FY26 and ratified the re-appointment of key board members during its 28th Annual General Meeting held on July 29, 2026. The virtual meeting, conducted via Video Conference/Other Audio-Visual Means (VC/OAVM) in compliance with the Companies Act, 2013 and SEBI Listing Regulations, saw high participation with 90,558 shareholders on the record date. The declaration underscores continued profitability, while the voting results reveal nuanced shareholder sentiment regarding specific director appointments.

The meeting commenced at 10:00 A.M. (IST) and concluded with the unblocking of votes at 11:20 A.M. Remote e-voting was facilitated by National Securities Depository Limited (NSDL) from July 25, 2026, to July 28, 2026. M/s. KVSS & CO. LLP, represented by CS K.V.S. Subramanyam, served as the scrutinizer. The statutory auditors, M/s. S.R. Batliboi & Associates LLP, confirmed an unqualified audit report for FY26, supporting the financial integrity of the dividend declaration.

Voting Results and Resolutions

Shareholders overwhelmingly supported the adoption of audited standalone and consolidated financial statements for FY26 (Resolution 1), with 99.9999% of votes cast in favor. Similarly, the dividend declaration (Resolution 2) received 99.9999% support, reflecting strong confidence in the company’s cash distribution strategy. The remuneration payable to cost auditors M/s. Lavanya and Associates LLP for FY27 (Resolution 4) was also approved with 99.9998% support.

Board Re-appointments and Mixed Sentiment

The re-appointment of Dr. Adarsh Kancharla as a Non-Executive Director (Resolution 3) received 68.23% support, with 31.77% votes against, indicating notable dissent among public institutional shareholders. In contrast, Dr. Ramesh Kancharla’s re-appointment as Chairman and Managing Director (Resolution 5) secured 99.90% support, while his remuneration package (Resolution 6) passed with 99.99% approval. Dr. Dinesh Kumar Chirla’s re-appointment as Whole-time Director (Resolution 7) and his remuneration (Resolution 8) also garnered near-unanimous support above 99.99%.

Independent director re-appointments faced moderate opposition. Mr. Santanu Mukherjee’s re-appointment (Resolution 9) received 97.14% support, with 2.86% against. Ms. Sundari R. Pisupati’s re-appointment (Resolution 10) saw similar results, with 97.11% in favor and 2.89% against. These dissenting votes primarily originated from public institutional shareholders, suggesting selective scrutiny of independent board composition.

What the Numbers Show

The near-unanimous approval of the dividend and financial statements highlights strong alignment between management and shareholders on core financial outcomes. However, the significant dissent against Dr. Adarsh Kancharla’s re-appointment and the moderate opposition to independent directors suggest growing shareholder activism regarding board governance and independence. This divergence implies that while operational performance is widely accepted, investors are increasingly exercising their voting rights to influence board structure and oversight mechanisms.

Rainbow Childrens Medicare has scheduled an earnings conference call for July 31, 2026, to discuss its financial and operating performance for the quarter ended June 30, 2026. The event provides investors and analysts with a direct channel to review the company’s Q1FY27 results and strategic direction. This disclosure ensures transparency regarding the firm’s recent operational outcomes ahead of broader market commentary.

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015. Shreya Mitra, Company Secretary and Compliance Officer, issued the intimation on July 23, 2026. The filing was submitted to both the National Stock Exchange of India Limited and BSE Limited.

Conference Call Details

The conference call is set for Friday, July 31, 2026, at 10:00 AM IST. IIFL Capital Markets will facilitate the event, providing dial-in options for participants across India and international markets including the USA, UK, Singapore, and Hong Kong. A pre-registration link via Diamond Pass is available for attendees.

Management Participants

The discussion will feature key executives from Rainbow Childrens Medicare Limited. The panel includes leadership responsible for overall strategy, financial oversight, and investor relations.

• Dr. Ramesh Kancharla, Chairman and MD
• Abrar Ali Dalal, Group Chief Executive Officer
• Vikas Maheshwari, Group Chief Financial Officer
• Saurabh Bhandari, Head IR & Business Intelligence

Investor Contact Information

For further information regarding the conference call or corporate inquiries, investors may contact the designated representatives at IIFL Capital Markets:

• Rahul Jeewani: +91 22 4646 4673
• Naman Bagrecha: +91 22 4646 4718
• Aman Goyal: +91 22 4646 4705
• Vighnesh Indure: +91 22 4646 4661

The company maintains its registered office in Banjara Hills, Hyderabad, and operates hospitals across Bengaluru, Chennai, Delhi, Guwahati, Hyderabad, Rajahmundry, Vijayawada, Visakhapatnam, and Warangal.